These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 25819278

  • 41. Improving the systemic drug delivery efficacy of nanoparticles using a transferrin variant for targeting.
    Chiu RY, Tsuji T, Wang SJ, Wang J, Liu CT, Kamei DT.
    J Control Release; 2014 Apr 28; 180():33-41. PubMed ID: 24524898
    [Abstract] [Full Text] [Related]

  • 42. Nanoparticles for drug delivery in cancer treatment.
    Haley B, Frenkel E.
    Urol Oncol; 2008 Apr 28; 26(1):57-64. PubMed ID: 18190833
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer.
    Tanaka S, Iwamoto M, Kimura K, Matsunami N, Morishima H, Yoshidome K, Nomura T, Morimoto T, Yamamoto D, Tsubota Y, Kobayashi T, Uchiyama K.
    Clin Breast Cancer; 2015 Jun 28; 15(3):191-6. PubMed ID: 25579459
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles.
    Xu Q, Liu Y, Su S, Li W, Chen C, Wu Y.
    Biomaterials; 2012 Feb 28; 33(5):1627-39. PubMed ID: 22118775
    [Abstract] [Full Text] [Related]

  • 48. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
    Tortorella S, Karagiannis TC.
    Curr Drug Deliv; 2014 Feb 28; 11(4):427-43. PubMed ID: 24387131
    [Abstract] [Full Text] [Related]

  • 49. Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity.
    Pulkkinen M, Pikkarainen J, Wirth T, Tarvainen T, Haapa-aho V, Korhonen H, Seppälä J, Järvinen K.
    Eur J Pharm Biopharm; 2008 Sep 28; 70(1):66-74. PubMed ID: 18555675
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
    Jiang X, Sha X, Xin H, Chen L, Gao X, Wang X, Law K, Gu J, Chen Y, Jiang Y, Ren X, Ren Q, Fang X.
    Biomaterials; 2011 Dec 28; 32(35):9457-69. PubMed ID: 21911250
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.